Tenaya Therapeutics, Inc. (TNYA) Tops Q2 EPS by 5c

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q2 EPS of ($0.34), $0.05 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.

You May Also Be Interested In

• Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
• Five Below (FIVE) Tops Q2 EPS by 35c, Beats on Revenue; Offers Q3 Revenue Guidance
• Netskope, Inc. (NTSK) Tops Q2 EPS by 4c, Offers Guidance